Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy

Head and neck squamous cell cancer (HNSCC) is the sixth most common malignancy worldwide, and despite advances in cytotoxic, surgical and radiation techniques, outcomes are still poor in those with both locally advanced and metastatic diseases. The need for development of better therapeutics along w...

Descripción completa

Detalles Bibliográficos
Autores principales: Haque, Sulsal, Yellu, Mahender, Randhawa, Jaskirat, Hashemi-Sadraei, Nooshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587117/
https://www.ncbi.nlm.nih.gov/pubmed/28919706
http://dx.doi.org/10.2147/DDDT.S119537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587117/
https://www.ncbi.nlm.nih.gov/pubmed/28919706
http://dx.doi.org/10.2147/DDDT.S119537

Ejemplares similares